DIGIPHARM: BRINGING VALUE-BASED HEALTHCARE TO LIFE USING BLOCKCHAIN TECHNOLOGY

The healthcare system is a major anchor of the society today as the world cannot do without quality healthcare. Health is vital to the human race as poor or ill health affects every other sector or system of the society. Today, the healthcare sector has witnessed significant improvement and technological evolution, but not without challenges.
The complexity and cost of getting real-world data for use by the healthcare sector has become a challenge. Another challenge is the requirement for the healthcare system to make the difficult decision of reimbursing costly pharmacological therapies and providing access for patients while taking into account their limited resources. Innovative pricing approaches have the ability to overcome this challenge, but the healthcare systems around the world still lack the required infrastructure to track and implement innovative pricing models such as value-based pricing agreements. Ordinarily, through innovative pricing, the healthcare systems will be able to gain access to funds for funding new drugs, as well as implement ‘flexible’ pricing schemes for everyone to assess the price of treatment in relation to the benefits it delivers. However, the lack of relevant infrastructure to track and implement innovative pricing models has led to the following:
• a reluctance to adopt such innovative policies
• pharmacological therapies being denied to patients who are most at need
• an opportunity missed to decrease the long term economic and disease burden on health systems
• a barrier to reimbursement for manufacturers.
The solution however isn’t far-fetched as Digipharm has come to make the healthcare system better.

INTRODUCING DIGIPHARM
Digipharm is a strong platform built for the healthcare sector with the aim of accelerating the much needed restructuring of healthcare delivery systems to a value-based approach. To improve the healthcare system, Digipharm wants to remove infrastructural barriers, and automate the implementation of the innovative value-based pricing agreements on a fully independent platform, so as to facilitate personalized reimbursement of health technology on a ‘fee for performance’ basis for the mutual benefit of patients, payers and manufacturers.
Digipharm has a vision of becoming the pioneer of value-based healthcare delivery, innovative evidence generation and patient empowerment across the healthcare industry via the revolutionary blockchain technology.

CURRENT REAL-WORLD DATA LIMITATIONS FACING THE HEALTHCARE
• Long delay in availability of outputs
• High cost and resource use required to generate or collect observational data
• Inconsistency and incompatibility of data arising from numerous sources
• Disparities in formatting methodologies between data collection centres
• Concerns over the privacy and security of patient data
• Fragmented data from a variety of sources that is time consuming to amalgamate and present in a consistent manner
• Absence of potentially useful information and lack of access to data for patients
• Non-incentives for patients to contribute data

DIGIPHARM’S SOLUTION
Digipharm will employ two different platforms/strategies in its solution:
• Reimburse: This platform uses the many benefits of automated ‘smart contracts’ and blockchain technology. It expedites integration, coordination and delivery of patient focused healthcare systems that helps improve the outcome of patients as well as accelerates the new innovative pricing system (‘payment for value’ mechanisms between payers and manufacturers using neutrally-enforceable agreements in a peer to peer fashion).

• Insights: This platform extracts anonymized level data from the reimburse platform and health information systems to the world’s first live RWE database. In essence, the Insights platform will supply a unique solution with the Reimburse platform that will aid in driving the evolution to value-based healthcare delivery systems.

Digipharm will significantly transform the current industry models for research and development as well as treatment pathways and healthcare funding, consequently leading us into the era of personalized healthcare. Digipharm will also help in improving patient health, providing timely access to patients, ensuring that the healthcare system is sustainable, plus rewarding and incentivising innovation in the development of new treatments.
It is worthy to note that, at the moment, no platform can compare with the Reimburse platform as it has the potential to become the leading platform that provides innovative pricing solutions for every therapy that gets approved in terms of regulation.
The Digipharm platforms (Reimburse and Insights) will use task automation, possibly through smart contract.

FEATURES OF THE DIGIPHARM PLATFORM
• Patient website and app
• Smart contracts for innovative pricing agreements and task automation
• Interface for Manufacturers/Payers/Providers
• Legal/Regulatory/Compliance mechanisms
• Integration into existing stakeholder I.T. infrastructure

DIGIPHARM HEALTH ECONOMY STAKEHOLDERS/PARTICIPANTS
• Digipharm Platforms
• Patients
• Payers
• Manufacturers
• Providers

DIGIPHARM FUTURE PROJECTS
• MyHealth (incentivising patients for superior outcomes)
• Evolve (supporting early medical innovation)

DIGIPHARM TOKEN (DPH)
The Digipharm Token (DPH) will be used for paying access/license fees on all Digipharm platforms.
Ticker code: DPH
DPH Supply: 100,000,000 Fixed (ERC-20)
Decimal Places: 18
Token Price: 1.00 USD

DIGIPHARM TOKEN SALE DETAILS

Pre - Sale: 15,000,000 DPH
Main Sale: 50,000,000 DPH
Base Price: 1.00 USD
Pre - Sale Length: 4 Weeks
Pre - Sale Discount: 35%
Week 1: 25% (Capped at 25 million tokens)
Week 2: 15% (Capped at 15 million tokens)
Week 3: 10% (Capped at 10 million tokens)
Week 4: 1.00 USD

TOKEN DISTRIBUTION

65% (ICO)
20% (Team/Partners)
14% (Reserve / Product Development)
1% (Referrals / Bounties)

FUND USE

15% (Legal % Regulatory)
4% (Marketing)
0.5% (Charity Foundation)
65% (Product Development)
15.5% (Professional services)

DIGIPHARM TEAM
Ahmed Abdulla (Founder/CEO)
Girisha Fernando (Co-Founder/COO)
Zach Daniels (CTO)
Ralf Gerteis (Commercial Strategy)
Meredith Darden (Digital Marketing Lead)
Michael Gubert (UI/UX Design)
Alexey Popov (Web Development)
Alexander Sverdlov (Cybersecurity Strategy)
Dr. Mohamed Abdulla (Clinical Transformation)
Bobby Kaura (Business Development)
Rolf Günter (Legal Counsel)
Leon Rebolledo (Lead Architect)
Peter Sandbach (Communications Director)
Dr. Rami Radwan (Clinical Relations)
Ali Al-Sudani (Clinical Pharmacist)
Dr. Hasham Al-Meshhedani (Patient Engagement)
Marko Granic (Graphic Designer)
Debra De Silva-Sun (HEOR & Pricing Analyst)

DIGIPHARM ADVISORS
Sven Möller - ICO Advisor (Swisscom Blockchain AG)
Kamal Youssefi - Enterprise Blockchain Advisor (Swisscom Blockchain AG)
Waldemar Scherer - Life Sciences Blockchain Advisor (Swisscom Blockchain AG)
Sam Mantle - Health & Life Sciences Technology Advisor (Luxoft)
Lloyd Jefferies - CRM Advisor (KPMG)
Anas Aman - Quality and Testing (IBM)
Claudio Staub - Co-Head Startup Communications (Farner Consulting AG)
Daniel Heller - PR Advisor (Partner, Farner Consulting AG)
Fadi Chehadah - Health Economist (NICE UK)
Per-Olof Thuresson - Health Economist (Roche)

DIGIPHARM PARTNERS
FRORIEP
SWISS DIGITAL HEALTH
SWISSCOM BLOCKCHAIN
FARNER

Digipharm will surely evolve the entire healthcare sector via the features and solution that it offers to existing problems.
I, therefore, urge you to partake in the Digipharm token sale event.

Feel free to click on any of the following links should you need more information on the Digipharm project or want to connect with other unique participants:
Website: https://www.digipharm.ch/
ANN thread: https://bitcointalk.org/index.php?topic=3083623.0
Whitepaper: https://digipharm.ch/docs/DigipharmWP.pdf
Facebook: https://www.facebook.com/digipharmteam/
Twitter: https://twitter.com/DigipharmTeam
Telegram: https://t.me/joinchat/ExOHxk-TuOplQDbBWXaLaQ

Published by: Dhevi
Bitcointalk URL: https://bitcointalk.org/index.php?action=profile;u=1567105
Ethereum wallet address: 0xA7Da3eDaa862830D59a81d35EE50DAD9A11Ec500